Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.

Twenty-one malaria-naive volunteers were immunized with a vaccine consisting of a 22-kDa recombinant peptide (R32LR), derived from the repeat region of Plasmodium falciparum circumsporozoite (CS) protein, covalently coupled to detoxified Pseudomonas aeruginosa toxin A. Nineteen volunteers received a...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Infect Immun
Asıl Yazarlar:	Fries, L F, Gordon, D M, Schneider, I, Beier, J C, Long, G W, Gross, M, Que, J U, Cryz, S J, Sadoff, J C
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1992
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC257081/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1563771/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.60.5.1834-1839.1992
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.

Benzer Materyaller